LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $77.29 million. The enterprise value is $72.24 million.
| Market Cap | 77.29M |
| Enterprise Value | 72.24M |
Important Dates
The last earnings date was Thursday, August 27, 2026, after market close.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Sep 1, 2026 |
Share Statistics
LifeVantage has 12.53 million shares outstanding. The number of shares has decreased by -2.20% in one year.
| Current Share Class | 12.53M |
| Shares Outstanding | 12.53M |
| Shares Change (YoY) | -2.20% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 18.86% |
| Owned by Institutions (%) | 42.38% |
| Float | 8.75M |
Valuation Ratios
The trailing PE ratio is 15.43 and the forward PE ratio is 19.08.
| PE Ratio | 15.43 |
| Forward PE | 19.08 |
| PS Ratio | 0.42 |
| Forward PS | 0.47 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | 11.59 |
| P/OCF Ratio | 7.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.63, with an EV/FCF ratio of 10.83.
| EV / Earnings | 14.24 |
| EV / Sales | 0.40 |
| EV / EBITDA | 7.63 |
| EV / EBIT | 10.78 |
| EV / FCF | 10.83 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.89 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 1.48 |
| Interest Coverage | 136.73 |
Financial Efficiency
Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 18.80%.
| Return on Equity (ROE) | 14.87% |
| Return on Assets (ROA) | 6.25% |
| Return on Invested Capital (ROIC) | 18.80% |
| Return on Capital Employed (ROCE) | 16.00% |
| Weighted Average Cost of Capital (WACC) | 7.52% |
| Revenue Per Employee | $818,771 |
| Profits Per Employee | $22,744 |
| Employee Count | 223 |
| Asset Turnover | 2.72 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, LifeVantage has paid $994,000 in taxes.
| Income Tax | 994,000 |
| Effective Tax Rate | 16.39% |
Stock Price Statistics
The stock price has decreased by -45.06% in the last 52 weeks. The beta is 0.76, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -45.06% |
| 50-Day Moving Average | 6.41 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 41.96 |
| Average Volume (20 Days) | 53,960 |
Short Selling Information
The latest short interest is 1.21 million, so 9.64% of the outstanding shares have been sold short.
| Short Interest | 1.21M |
| Short Previous Month | 1.26M |
| Short % of Shares Out | 9.64% |
| Short % of Float | 13.81% |
| Short Ratio (days to cover) | 16.23 |
Income Statement
In the last 12 months, LifeVantage had revenue of $182.59 million and earned $5.07 million in profits. Earnings per share was $0.40.
| Revenue | 182.59M |
| Gross Profit | 141.61M |
| Operating Income | 6.70M |
| Pretax Income | 6.07M |
| Net Income | 5.07M |
| EBITDA | 9.47M |
| EBIT | 6.70M |
| Earnings Per Share (EPS) | $0.40 |
Balance Sheet
The company has $14.92 million in cash and $9.87 million in debt, with a net cash position of $5.05 million or $0.40 per share.
| Cash & Cash Equivalents | 14.92M |
| Total Debt | 9.87M |
| Net Cash | 5.05M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 33.59M |
| Book Value Per Share | 2.68 |
| Working Capital | 18.07M |
Cash Flow
In the last 12 months, operating cash flow was $10.24 million and capital expenditures -$3.57 million, giving a free cash flow of $6.67 million.
| Operating Cash Flow | 10.24M |
| Capital Expenditures | -3.57M |
| Depreciation & Amortization | 2.77M |
| Net Borrowing | n/a |
| Free Cash Flow | 6.67M |
| FCF Per Share | $0.53 |
Margins
Gross margin is 77.56%, with operating and profit margins of 3.67% and 2.78%.
| Gross Margin | 77.56% |
| Operating Margin | 3.67% |
| Pretax Margin | 3.32% |
| Profit Margin | 2.78% |
| EBITDA Margin | 5.19% |
| EBIT Margin | 3.67% |
| FCF Margin | 3.65% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 3.24%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 3.24% |
| Dividend Growth (YoY) | 11.76% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 50.00% |
| Buyback Yield | 2.20% |
| Shareholder Yield | 5.44% |
| Earnings Yield | 6.56% |
| FCF Yield | 8.63% |
Analyst Forecast
The average price target for LifeVantage is $7.50, which is 21.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 21.56% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -2.54% |
| EPS Growth Forecast (3Y) | -17.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
LifeVantage has an Altman Z-Score of 3.4 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.4 |
| Piotroski F-Score | 5 |